Blog

Midven’s Rainbow Seed Fund, along with SynbiCITE, a pioneering Innovation and Knowledge Centre (IKC), have announced the launch of Bio-start. This annual competition, worth £200,000 to the successful UK innovator, will help early-stage synthetic biology innovators to move ground-breaking ideas closer to the market. The science of synthetic biology Synthetic biology lies at the cross […]

read more

The Minister for Life Sciences George Freeman MP has launched the UK Synthetic Biology Strategic Plan 2016. The ‘Biodesign for the Bioeconomy’ plan builds on the success of the 2012 Synthetic Biology Roadmap for the UK with a strong focus on the applications of the technology, in particular it focuses on five strategic areas: Accelerating […]

read more

The cross-disciplinary field of synthetic biology allows scientists to design and engineer organisms to carry out new roles, has been put to solving another challenge – that of creating a vaccine against the sexually transmitted disease chlamydia. Caused by an infection with the bacterium Chlamydia trachomatis,chlamydia is one of the most common sexually transmitted diseases […]

read more

1 2 3